Title Expression of PD-1 on CD4(+) Tumor-Infiltrating Lymphocytes in Tumor Microenvironment Associated with Pathological Characteristics of Breast Cancer
Authors Zhao, Yan-Jie
Zhang, Jian
Shi, Feng
Hu, Zhi-Ping
Wu, Jiang-Ping
Wu, Guang-Jiang
Wang, Rui-Bin
Zhou, Quan
Chang, Hong
Li, Ying-Nan
Song, Qing-Kun
Affiliation Capital Med Univ, Beijing Shijitan Hosp, Dept Med Oncol, Beijing 100038, Peoples R China.
Capital Med Univ, Beijing Chaoyang Hosp, Dept Emergency, Beijing 100020, Peoples R China.
Capital Med Univ, Beijing Shijitan Hosp, Dept Pathol, Beijing 100038, Peoples R China.
Peking Univ, Peoples Hosp, Dept Hepatobiliary Surg, Beijing 100021, Peoples R China.
Capital Med Univ, Beijing Shijitan Hosp, Dept Canc Res, Beijing 100038, Peoples R China.
Capital Med Univ, Beijing Shijitan Hosp, Dept Infect Control, Beijing 100038, Peoples R China.
Capital Med Univ, Beijing Shijitan Hosp, Dept Emergency, Beijing 100038, Peoples R China.
Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Gastroenterol, Beijing 100853, Peoples R China.
Capital Med Univ, Beijing Shijitan Hosp, Dept Sci & Technol, Beijing 100038, Peoples R China.
Beijing Key Lab Canc Therapeut Vaccine, Beijing, Peoples R China.
Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Gastroenterol, Beijing 100853, Peoples R China.
Song, QK (reprint author), Capital Med Univ, Beijing Shijitan Hosp, Dept Sci & Technol, Beijing 100038, Peoples R China.
Song, QK (reprint author), Beijing Key Lab Canc Therapeut Vaccine, Beijing, Peoples R China.
Keywords T-CELLS
KI67
LEUKEMIA
PROGNOSIS
CARCINOMA
SURVIVAL
ANTIGEN
ROLES
STAGE
TILS
Issue Date 2018
Publisher JOURNAL OF IMMUNOLOGY RESEARCH
Citation JOURNAL OF IMMUNOLOGY RESEARCH. 2018.
Abstract Objective. This study aimed to investigate the correlation of CD4(+)/PD-1(+) or CD4(+)/PD-1(-) tumor-infiltrating lymphocytes with pathological characteristics in breast cancer patients. Methods. A cross-sectional study consecutively recruited 133 patients with invasive ductal breast cancer. The expression of CD4, programmed cell death protein 1 (PD-1), CK7, CK20, E-cadherin, or Ki-67 was detected by immunohistochemistry. The associations between CD4(+)/PD-1(+) or CD4(+)/PD-1(-) tumor-infiltrating lymphocytes and pathological characteristics were evaluated. Results. Elderly patients intended to have a lower level of CD4(+)/PD-1(-) tumorinfiltrating lymphocytes (p <0.05). Patients with positive E-cadherin expression had higher median cell counts of CD4(+)/PD-1 tumor-infiltrating lymphocytes than patients with negative E-cadherin expression (30/HPF versus 10/HPF, p < 0.05). Counts of CD4(+)/PD-1(+) tumor-infiltrating lymphocytes had a significant correlation with Ki-67 index that the correlation coefficient was 0.29 (p = 0.001). Positive CK20 expression was related to a higher level of CD4(+)/PD-1(-) tumor-infiltrating lymphocytes than negative CK20 expression (73/HPF versus 30/HPF, p < 0.05). Conclusion. CDe/PD-1(+) or CD4(+)/PD-1(-) tumor-infiltrating lymphocytes showed diverse association with pathological features of breast cancer. CD4(+)/PD-1(+) tumor-infiltrating lymphocytes had a significant relationship with Ki-67 expression whereas CD4(+)/PD-1(-) tumor-infiltrating lymphocytes had a significant relationship with E-cadherin expression. Further studies are warranted to explore the immunomodulatory effects of phenotypes of CD4(+) T cell subsets in breast cancer.
URI http://hdl.handle.net/20.500.11897/524905
ISSN 2314-8861
DOI 10.1155/2018/5690258
Indexed SCI(E)
PubMed
Appears in Collections: 人民医院

Files in This Work
There are no files associated with this item.

Web of Science®


0

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.